Invention Grant
US08546613B2 SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
有权
用于预防和/或治疗病毒性疾病和/或癌症的SGK1抑制剂
- Patent Title: SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
- Patent Title (中): 用于预防和/或治疗病毒性疾病和/或癌症的SGK1抑制剂
-
Application No.: US12867963Application Date: 2009-02-17
-
Publication No.: US08546613B2Publication Date: 2013-10-01
- Inventor: Thomas Fuchss , Rolf Gericke , Norbert Beier , Florian Lang , Phillipp Lang , Karl Lang
- Applicant: Thomas Fuchss , Rolf Gericke , Norbert Beier , Florian Lang , Phillipp Lang , Karl Lang
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102008010361 20080218
- International Application: PCT/EP2009/001099 WO 20090217
- International Announcement: WO2009/103484 WO 20090827
- Main IPC: C07C243/28
- IPC: C07C243/28 ; A61K31/16
Abstract:
The present invention relates to a compound of formulas I, Ia, Ib and II, wherein R1 to R11 are herein defined.
Public/Granted literature
- US20110060050A1 SGK1 INHIBITORS FOR THE PROPHYLAXIS AND/OR THERAPY OF VIRAL DISEASES AND/OR CARCINOMAS Public/Granted day:2011-03-10
Information query
